FDA approves clinical trial of ecstasy for possible treatment of PTSD
 |
(NaturalNews) Could ecstasy soon be hitting a pharmacy near you? The FDA recently approved of a large-scale, Phase 3 clinical trial of MDMA for post-traumatic stress disorder. The approval follows a series of small-scale studies that have indicated that small amounts of the drug can provide effective treatment for the illness. While it may sound… |
Read Original Article: FDA approves clinical trial of ecstasy for possible treatment of PTSD »
Powered by WPeMatico
